(Q72022186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Response to interferon alpha therapy is influenced by the iron content of the liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

D H Van Thiel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

L Friedlander

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S Fagiuoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

H I Wright

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

W Irish

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J S Gavaler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 March 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

410-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Use of α-interferon in the treatment of chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Treatment of chronic hepatitis B with interferon: experience in western countries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Treatment of chronic hepatitis B with interferon: experience in Asian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Role of Iron in Microbe-Host Interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates rever

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Killing of gram-negative bacteria by lactoferrin and lysozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Letter: Elevated serum iron levels and persistent Australia antigen (HBsAG)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Serum ferritin as a predictor of host response to hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Statistical analysis of relationship between iron accumulation and hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Iron withholding: a defense against infection and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Day-to-day variation in iron-status indices in healthy men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Measurements of iron status in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Chelate mediated transfer of iron from transferrin to desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

Ascorbic acid and iron metabolism: alterations in lysosomal function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980017-0

7 January 2021

10.1016/S0168-8278(94)80017-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8014455%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference